Ameliorating effect of leukotriene receptor antagonist in multi-organ toxicity induced in rat offspring, a possible role for epidermal growth factor

Immunopharmacol Immunotoxicol. 2021 Apr;43(2):183-191. doi: 10.1080/08923973.2021.1878213. Epub 2021 Jan 27.

Abstract

Purpose: Nowadays, there is a dramatic increase in the interest of potential impact of consumer-relevant engineered nanoparticles on pregnancy.Materials and methods: This study investigated the possible protective effect of montelukast in neonatal organ toxicity induced by maternal exposure to silver nanoparticles (AgNPs) in rats.Results: It was noticed that montelukast reduced serum urea, creatinine, renal caspase-3 immunoreactivity and IL-1β and increased total antioxidant capacity, as compared to AgNPs. In kidney and bone tissue, montelukast reduced oxidative stress parameters and TNF-α level that was increased with AgNPs. Surprisingly, montelukast administration increased epidermal growth factor (EGF) in bone and reduced it in kidney. Furthermore, as compared to AgNPs, montelukast improved histopathological picture of kidney and bone.Conclusions: In conclusion, montelukast antagonized the biochemical and histopathological changes occurred in kidneys and bones of rat offspring by maternal exposure to AgNPs, mostly by anti-oxidant, anti-apoptotic and anti-inflammatory actions with a possible role for EGF.

Keywords: Epidermal growth factor; montelukast; multi-organ toxicity; rat offspring; silver nanoparticles.

MeSH terms

  • Acetates / pharmacology*
  • Acetates / therapeutic use
  • Animals
  • Calcification, Physiologic / drug effects*
  • Calcification, Physiologic / physiology
  • Cyclopropanes / pharmacology*
  • Cyclopropanes / therapeutic use
  • Epidermal Growth Factor / metabolism*
  • Female
  • Kidney / drug effects*
  • Kidney / metabolism*
  • Kidney / pathology
  • Leukotriene Antagonists / pharmacology*
  • Leukotriene Antagonists / therapeutic use
  • Male
  • Metal Nanoparticles / toxicity
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Pregnancy
  • Prenatal Exposure Delayed Effects / chemically induced
  • Prenatal Exposure Delayed Effects / drug therapy
  • Prenatal Exposure Delayed Effects / metabolism
  • Quinolines / pharmacology*
  • Quinolines / therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Leukotriene / metabolism
  • Silver / toxicity
  • Sulfides / pharmacology*
  • Sulfides / therapeutic use

Substances

  • Acetates
  • Cyclopropanes
  • Leukotriene Antagonists
  • Quinolines
  • Receptors, Leukotriene
  • Sulfides
  • Silver
  • Epidermal Growth Factor
  • montelukast